ProPhase Labs Inc (PRPH)
5.42
+0.11
(+2.07%)
USD |
NASDAQ |
May 03, 16:00
5.47
+0.05
(+0.92%)
After-Hours: 20:00
ProPhase Labs Free Cash Flow: -14.50M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.50M |
| September 30, 2023 | -13.76M |
| June 30, 2023 | -6.365M |
| March 31, 2023 | 5.399M |
| December 31, 2022 | 24.63M |
| September 30, 2022 | 20.80M |
| June 30, 2022 | 13.18M |
| March 31, 2022 | 13.16M |
| December 31, 2021 | -17.85M |
| September 30, 2021 | -21.46M |
| June 30, 2021 | -16.48M |
| March 31, 2021 | -16.27M |
| December 31, 2020 | -4.281M |
| September 30, 2020 | 3.483M |
| June 30, 2020 | 3.038M |
| March 31, 2020 | -2.255M |
| December 31, 2019 | -1.069M |
| September 30, 2019 | -1.495M |
| June 30, 2019 | -1.795M |
| March 31, 2019 | -0.738M |
| December 31, 2018 | -2.259M |
| September 30, 2018 | -3.094M |
| June 30, 2018 | -2.308M |
| March 31, 2018 | -6.177M |
| December 31, 2017 | -3.046M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.148M |
| June 30, 2017 | -1.407M |
| March 31, 2017 | 1.049M |
| December 31, 2016 | -1.123M |
| September 30, 2016 | -2.341M |
| June 30, 2016 | -5.032M |
| March 31, 2016 | -5.512M |
| December 31, 2015 | -4.215M |
| September 30, 2015 | -5.091M |
| June 30, 2015 | -4.112M |
| March 31, 2015 | -4.372M |
| December 31, 2014 | -3.528M |
| September 30, 2014 | -0.862M |
| June 30, 2014 | -1.71M |
| March 31, 2014 | -0.14M |
| December 31, 2013 | 0.695M |
| September 30, 2013 | -2.356M |
| June 30, 2013 | -1.817M |
| March 31, 2013 | -2.997M |
| December 31, 2012 | -6.039M |
| September 30, 2012 | -2.801M |
| June 30, 2012 | -3.684M |
| March 31, 2012 | -2.869M |
| December 31, 2011 | -2.408M |
| September 30, 2011 | -3.806M |
Free Cash Flow Range, Past 5 Years
-21.46M
Minimum
Sep 2021
24.63M
Maximum
Dec 2022
-1.784M
Average
-1.795M
Median
Jun 2019
Free Cash Flow Benchmarks
| Fonar Corp | 12.18M |
| XWELL Inc | -18.45M |
| Applied DNA Sciences Inc | -7.592M |
| Veracyte Inc | 34.26M |
| OncoCyte Corp | -23.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.213M |
| Cash from Investing (Quarterly) | -1.264M |
| Cash from Financing (Quarterly) | 2.924M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow to Equity (Quarterly) | -4.482M |
| Free Cash Flow to Firm (Quarterly) | -1.182M |
| Free Cash Flow Yield | -15.26% |